300 related articles for article (PubMed ID: 31181215)
1. PPP1R3C mediates metformin-inhibited hepatic gluconeogenesis.
Ji X; Wang S; Tang H; Zhang Y; Zhou F; Zhang L; Zhu Q; Zhu K; Liu Q; Liu Y; Wang X; Zhou L
Metabolism; 2019 Sep; 98():62-75. PubMed ID: 31181215
[TBL] [Abstract][Full Text] [Related]
2. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
[TBL] [Abstract][Full Text] [Related]
3. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
[TBL] [Abstract][Full Text] [Related]
4. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
[TBL] [Abstract][Full Text] [Related]
5. Role of serum- and glucocorticoid-inducible kinase 1 in the regulation of hepatic gluconeogenesis.
Xu Z; Wang Y; Liu Q; Wang S; Sheng C; Chen J; Tan J; Wang X; Shao L; Zhou L
J Mol Endocrinol; 2023 Aug; 71(2):. PubMed ID: 37283531
[TBL] [Abstract][Full Text] [Related]
6. Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5.
Caton PW; Nayuni NK; Kieswich J; Khan NQ; Yaqoob MM; Corder R
J Endocrinol; 2010 Apr; 205(1):97-106. PubMed ID: 20093281
[TBL] [Abstract][Full Text] [Related]
7. Role of KLF15 in regulation of hepatic gluconeogenesis and metformin action.
Takashima M; Ogawa W; Hayashi K; Inoue H; Kinoshita S; Okamoto Y; Sakaue H; Wataoka Y; Emi A; Senga Y; Matsuki Y; Watanabe E; Hiramatsu R; Kasuga M
Diabetes; 2010 Jul; 59(7):1608-15. PubMed ID: 20393151
[TBL] [Abstract][Full Text] [Related]
8. Suppressor of cytokine signalling-2 controls hepatic gluconeogenesis and hyperglycemia by modulating JAK2/STAT5 signalling pathway.
Zhang X; Zhuang Y; Qin T; Chang M; Ji X; Wang N; Zhang Z; Zhou H; Wang Q; Li JZ
Metabolism; 2021 Sep; 122():154823. PubMed ID: 34197875
[TBL] [Abstract][Full Text] [Related]
9. Role of hepatic neuregulin 4 in the regulation of gluconeogenesis in mice.
Zhang L; Bai M; Tang H; Zhou F; Zhu Q; Wang S; Zhu K; Liu Q; Liu Y; Wang X; Ma Y; Zhou L
Life Sci; 2019 Jan; 217():185-192. PubMed ID: 30528184
[TBL] [Abstract][Full Text] [Related]
10. AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner.
Lee JM; Seo WY; Song KH; Chanda D; Kim YD; Kim DK; Lee MW; Ryu D; Kim YH; Noh JR; Lee CH; Chiang JY; Koo SH; Choi HS
J Biol Chem; 2010 Oct; 285(42):32182-91. PubMed ID: 20688914
[TBL] [Abstract][Full Text] [Related]
11. Metformin suppresses hepatic gluconeogenesis and lowers fasting blood glucose levels through reactive nitrogen species in mice.
Fujita Y; Hosokawa M; Fujimoto S; Mukai E; Abudukadier A; Obara A; Ogura M; Nakamura Y; Toyoda K; Nagashima K; Seino Y; Inagaki N
Diabetologia; 2010 Jul; 53(7):1472-81. PubMed ID: 20349346
[TBL] [Abstract][Full Text] [Related]
12. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
[TBL] [Abstract][Full Text] [Related]
13. Effects of eugenol on hepatic glucose production and AMPK signaling pathway in hepatocytes and C57BL/6J mice.
Jeong KJ; Kim DY; Quan HY; Jo HK; Kim GW; Chung SH
Fitoterapia; 2014 Mar; 93():150-62. PubMed ID: 24418657
[TBL] [Abstract][Full Text] [Related]
14. Metformin induces PGC-1α expression and selectively affects hepatic PGC-1α functions.
Aatsinki SM; Buler M; Salomäki H; Koulu M; Pavek P; Hakkola J
Br J Pharmacol; 2014 May; 171(9):2351-63. PubMed ID: 24428821
[TBL] [Abstract][Full Text] [Related]
15. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.
Shaw RJ; Lamia KA; Vasquez D; Koo SH; Bardeesy N; Depinho RA; Montminy M; Cantley LC
Science; 2005 Dec; 310(5754):1642-6. PubMed ID: 16308421
[TBL] [Abstract][Full Text] [Related]
16. Novel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes.
Saberi M; Bjelica D; Schenk S; Imamura T; Bandyopadhyay G; Li P; Jadhar V; Vargeese C; Wang W; Bowman K; Zhang Y; Polisky B; Olefsky JM
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1137-46. PubMed ID: 19706791
[TBL] [Abstract][Full Text] [Related]
17. CREB-upregulated lncRNA MEG3 promotes hepatic gluconeogenesis by regulating miR-302a-3p-CRTC2 axis.
Zhu X; Li H; Wu Y; Zhou J; Yang G; Wang W; Kang D; Ye S
J Cell Biochem; 2019 Mar; 120(3):4192-4202. PubMed ID: 30260029
[TBL] [Abstract][Full Text] [Related]
18. Baicalin ameliorates hepatic insulin resistance and gluconeogenic activity through inhibition of p38 MAPK/PGC-1α pathway.
Fang P; Sun Y; Gu X; Shi M; Bo P; Zhang Z; Bu L
Phytomedicine; 2019 Nov; 64():153074. PubMed ID: 31473580
[TBL] [Abstract][Full Text] [Related]
19. Insulin-Inducible SMILE Inhibits Hepatic Gluconeogenesis.
Lee JM; Seo WY; Han HS; Oh KJ; Lee YS; Kim DK; Choi S; Choi BH; Harris RA; Lee CH; Koo SH; Choi HS
Diabetes; 2016 Jan; 65(1):62-73. PubMed ID: 26340929
[TBL] [Abstract][Full Text] [Related]
20. Expression profile analysis of long non-coding RNAs involved in the metformin-inhibited gluconeogenesis of primary mouse hepatocytes.
Wang Y; Tang H; Ji X; Zhang Y; Xu W; Yang X; Deng R; Liu Y; Li F; Wang X; Zhou L
Int J Mol Med; 2018 Jan; 41(1):302-310. PubMed ID: 29115403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
